← Back to Search

Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles

N/A
Waitlist Available
Led By Steven Radtke, MD
Research Sponsored by Texas Tech University Health Sciences Center, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90-110 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether adding extra stitches at the corners of the vaginal wound before using a special type of thread can reduce bleeding after a hysterectomy. The goal is to help patients recover better by preventing bothersome bleeding that often occurs after this surgery. This approach aims to make the wound stronger and less likely to bleed.

Eligible Conditions
  • Postoperative Hemorrhage
  • Complications
  • Patient Satisfaction
  • Operative Time

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the surgery. start time begins when first suture and sewing instruments are in abdomen with the intention of closing vaginal cuff. stop time is when last suture pertaining to vaginal cuff closure/apex stitches is cut.
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the surgery. start time begins when first suture and sewing instruments are in abdomen with the intention of closing vaginal cuff. stop time is when last suture pertaining to vaginal cuff closure/apex stitches is cut. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
pain quantification on 0-10 scale
postoperative bleeding frequency
postoperative bleeding volume
+1 more
Secondary study objectives
ER visits
General healthSF36
Operative time
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Angle stitchExperimental Treatment1 Intervention
If the allocation corresponds to "Angle stitch", surgeon will use 0 polyglactin 910 suture on a tapered needle to place figure of 8 sutures on both (left and right) apexes. Knot tying technique (intra-corporeal vs extracorporeal) will be up to surgeon preference. After this is completed, barbed suture will be used to re-approximate the remainder of the vaginal cuff from right to left, backtracking once at the end for reinforcement.
Group II: controlActive Control1 Intervention
If the subject's group corresponds to "Control group", the surgeon will re-approximate the cuff in a standard fashion, using a running-barbed suture (2-0 V-LOC 90 with tapered needle), starting at the right apex, moving towards the left, and then back-tracking once to further reinforce the closure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Angle stitch
2022
N/A
~120

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences Center, El PasoLead Sponsor
49 Previous Clinical Trials
4,965 Total Patients Enrolled
Steven Radtke, MDPrincipal InvestigatorTexas Tech University Health and Sciences Center
1 Previous Clinical Trials
53 Total Patients Enrolled

Media Library

Angle stitch Clinical Trial Eligibility Overview. Trial Name: NCT05174988 — N/A
Postoperative Hemorrhage Research Study Groups: Angle stitch, control
Postoperative Hemorrhage Clinical Trial 2023: Angle stitch Highlights & Side Effects. Trial Name: NCT05174988 — N/A
Angle stitch 2023 Treatment Timeline for Medical Study. Trial Name: NCT05174988 — N/A
~31 spots leftby Dec 2025